CCR5 Expression Influences the Progression of Human Breast Cancer in a p53-dependent Manner

Journal of Experimental Medicine

Volumn 198, Issue 9, 2003, Pages 1381-1389

  Mañes, Santos ^a   Mira, Emilia ^a   Colomer, Ramón ^b,d   Montero, Sagrario ^b,e   Real, Luis M ^c   Gómez Moutón, Concepción ^a   Jiménez Baranda, Sonia ^a   Garzón, Alfredo ^b   Lacalle, Rosa Ana ^a   Harshman, Keith ^a,f   Ruíz, Agustín ^c   Martínez A, Carlos ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c Neocodex ^*  (Spain)

^d CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^e PHARMAMAR S A   (Spain)

^f UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Breast cancer; CCR5 polymorphism; Chemokine receptor; p38; p53

Indexed keywords

CHEMOKINE RECEPTOR CCR5; JANUS KINASE; JANUS KINASE 1; JANUS KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE; PERTUSSIS TOXIN; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; TRANSCRIPTION REGULATION; TUMOR XENOGRAFT;

BREAST NEOPLASMS; CELL DIVISION; DISEASE PROGRESSION; HUMANS; RECEPTORS, CCR5; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 16744362709     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20030580     Document Type: Article

References (37)

1. Murphy, P. 2001. Chemokines and molecular basis of cancer metastasis. N. Engl. J. Med. 354:833-835.
2. Balkwill, F., and A. Mantovani. 2001. Inflammation and cancer: back to Virchow? Lancet. 357:539-545.
3. Homey, B., A. Muller, and A. Zlotnik. 2002. Chemokines: agents for the immunotherapy of cancer? Nat. Rev. Immunol. 2:175-184.
4. Mashino, K., N. Sadanaga, H. Yamaguchi, F. Tanaka, M. Ohta, K. Shibuta, H. Inoue, and M. Mori. 2002. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res. 62:2937-2941.
5. Muller, A., B. Homey, H. Soto, N. Ge, D. Catron, M. Buchanan, T. McClanahan, E. Murphy, W. Yuan, S. Wagner, et al. 2001. Involvement of chemokine receptors in breast cancer metastasis. Nature. 410:50-56.
6. Taichman, R., C. Cooper, E. Keller, K. Pienta, N. Taichman, and L. McCauley. 2002. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res. 62:1832-1837.
7. Mule, J., M. Custer, B. Averbook, J. Yang, J. Weber, D. Goeddel, S. Rosenberg, and T. Schall. 1996. RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations. Hum. Gene Ther. 7:1545-1553.
8. Luboshits, G., S. Shina, O. Kaplan, S. Engelberg, D. Nass, B. Lifshitz-Mercer, S. Chaitchik, I. Keydar, and A. Ben-Baruch. 1999. Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. Cancer Res. 59:4681-4687.
9. Niwa, Y., H. Akamatsu, H. Niwa, H. Sumi, Y. Ozaki, and A. Abe. 2001. Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. Clin. Cancer Res. 7:285-289.
10. Mañes, S., E. Mira, C. Gomez-Mouton, R. Lacalle, P. Keller, J. Labrador, and C. Martinez-A. 1999. Membrane raft microdomains mediate front-rear polarity in migrating cells. EMBO J. 18:6211-6220.
11. Mira, E., R. Lacalle, M. Gonzalez, C. Gomez-Mouton, J. Abad, A. Bernad, C. Martinez-A., and S. Mañes. 2001. A role for chemokine receptor transactivation in growth factor signaling. EMBO Rep. 2:151-156.
12. Prest, S., R. Rees, C. Murdoch, J. Marshall, P. Cooper, M. Bibby, G. Li, and S. Ali. 1999. Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: subpopulations of tumour cells display positive and negative chemotaxis and differential in vivo growth potentials. Clin. Exp. Metastasis. 17:389-396.
13. Presta, M., M. Belleri, A. Vecchi, J. Hesselgesser, A. Mantovani, and R. Horuk. 1998. Noncompetitive, chemokine-mediated inhibition of basic fibroblast growth factor-induced endothelial cell proliferation. J. Biol. Chem. 273:7911-7919.
14. Del Real, G., S. Jiménez-Baranda, R. Lacalle, E. Mira, P. Lucas, C. Gomez-Mouton, A. Carrera, C. Martinez-A., and S. Mañes. 2002. Blocking of HIV-1 infection by targeting CD4 to nonraft membrane domains. J. Exp. Med. 196:293-301.
15. INK4a. Cell. 88:593-602.
16. Ruiz, A., J. Royo, A. Rubio, S. Borrego, M. Leal, B. Sanchez, A. Nuñez-Roldan, and G. Antinolo. 2001. Spectrofluorimetric analysis of CCR5-delta 32 allele using real-time polymerase chain reaction: prevalence in southern Spanish HIV(+) patients and noninfected population. AIDS Res. Hum. Retroviruses. 17:191-193.
17. Jordan-Sciutto, K., B. Murray-Fenner, C. Wiley, and C. Achim. 2001. Response of cell cycle proteins to neurotrophic factor and chemokine stimulation in human neuroglia. Exp. Neurol. 167:205-214.
18. Chelli, M., and M. Alizon. 2001. Determinants of the transdominant negative effect of truncated forms of the CCR5 chemokine receptor. J. Biol. Chem. 276:46975-46982.
19. Mellado, M., J. Rodriguez-Frade, S. Mañes, and C. Martinez-A. 2001. Chemokine signaling and functional responses: the role of receptor dimerization and TK pathway activation. Annu. Rev. Immunol. 19:397-421.
20. Raingeaud, J., A. Whitmarsh, T. Barrett, B. Derijard, and R. Davis. 1996. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16:1247-1255.
21. Dean, M., M. Carrington, C. Winkler, G. Huttley, M. Smith, R. Allikmets, J. Goedert, S. Buchbinder, E. Vittinghoff, E. Gomperts, et al. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science. 273:1856-1862.
22. Liu, R., W. Paxton, S. Choe, D. Ceradini, S. Martin, R. Horuk, M. MacDonald, H. Stuhlmann, R. Koup, and N. Landau. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 86:367-377.
23. Samson, M., F. Libert, B. Doranz, J. Rucker, C. Liesnard, C. Farber, S. Saragosti, C. Lapoumeroulie, J. Cognaux, C. Forceille, et al. 1996. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 382:722-725.
24. Cooke, S., G. Forrest, P. Venables, and A. Hajeer. 1998. The delta32 deletion of CCR5 receptor in rheumatoid arthritis. Arthritis Rheum. 41:1135-1136.
25. Gomez-Reino, J., J. Pablos, P. Carreira, B. Santiago, L. Serrano, J. Vicario, A. Balsa, M. Figueroa, and M. de Juan. 1999. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5. Arthritis Rheum. 42:989-992.
26. Zapico, I., E. Coto, A. Rodriguez, C. Alvarez, J. Torre, and V. Alvarez. 2000. CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis. Genes Immun. 1:288-289.
27. Sellebjerg, F., H. Madsen, C. Jensen, J. Jensen, and P. Garred. 2000. CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis. J. Neuroimmunol. 102:98-106.
28. Fischereder, M., B. Luckow, B. Hocher, R. Wüthrich, U. Rothenpieler, H. Schneeberger, U. Panzer, R. Stahl, I. Hauser, K. Budde, et al. 2001. CC chemokine receptor 5 and renal-transplant survival. Lancet. 357:1758-1761.
29. González, P., K. Alvárez, A. Batalla, J. Reguero, V. Alvárez, A. Astudillo, G. Cubero, A. Cortina, and E. Coto. 2001. Genetic variation at the chemokine receptors CCK5/CCK2 in myocardial infarction. Genes Immun. 2:191-195.
30. Montero, S., C. Guzman, C. Vargas, C. Ballestin, H. Cortes-Funes, and R. Colomer. 2001. Prognostic value of cytosolic p53 protein in breast cancer. Tumour Biol. 22:337-344.
31. Mellado, M., A. de Ana, M. Moreno, C. Martínez-A., and J. Rodriguez-Frade. 2001. A potential immune escape mechanism by melanoma cells through the activation of chemokine-induced T cell death. Curr. Biol. 11:691-696.
32. Kaul, M., and S. Lipton. 1999. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc. Natl. Acad. Sci. USA. 96:8212-8216.
33. Wong, M., S. Uddin, B. Majchrzak, T. Huynh, A. Proudfoot, L. Platanias, and E. Fish. 2001. Rantes activates Jak2 and Jak3 to regulate engagement of multiple signaling pathways in T cells. J. Biol. Chem. 276:11427-11431.
34. Bulavin, D., S. Saito, M. Hollander, K. Sakaguchi, C. Anderson, E. Appella, and A. Fornace. 1999. Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J. 18:6845-6854.
35. Sanchez-Prieto, R., J. Rojas, Y. Taya, and J. Gutkind. 2000. A role for the p38 mitogen-acitvated protein kinase pathway in the transcriptional activation of p53 on genotoxic stress by chemotherapeutic agents. Cancer Res. 60:2464-2472.
36. Woods, D., and K. Vousden. 2001. Regulation of p53 function. Exp. Cell Res. 264:56-66.
37. Taub, D., S. Turcovski, M. Key, D. Longo, and W. Murphy. 1996. Chemokines and T lymphocyte activation: I. Beta chemokines costimulate human T lymphocyte activation in vitro. J. Immunol. 156:2095-2103.